These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7472282)

  • 21. Different effects of pretreatment with 2-diethylaminoethyl-2,2-diphenylvalerate on the mouse liver polysomal disaggregation by dimethylnitrosamine and lasiocarpine.
    Garry VF; Lopez-Corella E; Plapp FV; Chiga M
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):117-22. PubMed ID: 5030700
    [No Abstract]   [Full Text] [Related]  

  • 22. Conversion of thyroxine to triiodothyronine in the anterior pituitary gland and the influence of this process on thyroid status.
    Kaplan MM; Breitbart R
    Horm Metab Res Suppl; 1984; 14():79-85. PubMed ID: 6595194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dosage, phenobarbital, and 2-diethylaminoethyl-2,2-diphenylvalerate on the binding of cyclophosphamide and-or its metabolites to the DNA, RNA, and protein of the embryo and liver in pregnant mice.
    Murthy VV; Becker BA; Steele WJ
    Cancer Res; 1973 Apr; 33(4):664-70. PubMed ID: 4696467
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of the metabolism of cocaine by SKF-525A.
    Estevez VS; Ho BT; Englert LF
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):179-82. PubMed ID: 877402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of SKF 525-A and adrenalectomy on the amino acid incorporation by rat liver microsomes from normal and CCl-4-treated rats.
    Smuckler EA; Hultin T
    Exp Mol Pathol; 1966 Oct; 5(5):504-15. PubMed ID: 5920449
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of repeated administration of rat 2-diethylaminoethyl-2-2-diphenylvalerate-HCI (SKF 525 A) on liver.
    Fernández G; Villarruel MC; Bernacchi A; de Castro CR; Castro JA
    Toxicology; 1981; 20(2-3):185-93. PubMed ID: 6167027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolism and disposition of aniline in the isolated blood-perfused liver of the rat.
    Boobis AR; Powis G
    Drug Metab Dispos; 1975; 3(2):63-8. PubMed ID: 236159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rate of aniline metabolism in vivo in rats exposed to aniline and drugs.
    Wiśniewska-Knypl JM; Jabłońska JK
    Xenobiotica; 1975 Aug; 5(8):511-9. PubMed ID: 1166665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of thyroidectomy, hypophysectomy, and hormone replacement on the formation of triiodothyronine from thyroxine in rat liver and kidney.
    Balsam A; Sexton F; Ingbar SH
    Endocrinology; 1978 Nov; 103(5):1759-67. PubMed ID: 748016
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of dietary manipulation on the in vitro generation of 3,5,3'-triiodothyronine from thyroxine in rat liver preparations.
    Balsam A; Sexton F; Ingbar SH
    Life Sci; 1981 Apr 13-20; 28(15-16):1727-36. PubMed ID: 7242258
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of pharmacological quantities of infused 3,3',5'-triiodothyronine on thyroxine monodeiodination to 3,5,3'-triiodothyronine.
    Coiro V; Harris A; Goodman HM; Vagenakis A; Braverman L
    Endocrinology; 1980 Jan; 106(1):68-75. PubMed ID: 7349974
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of diphenylhydantoin on intrapituitary conversion of T4 to T3 in rats].
    Ceppi JA; Zaninovich AA
    Medicina (B Aires); 1986; 46(4):418-22. PubMed ID: 3574104
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver.
    Wang Lu LJ; Demetriou SK; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):117-33. PubMed ID: 27150
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 35. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
    Chang TK; Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of SK&F 525-A, 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride, on the in vivo metabolism of beta-(0-toloxy)-1,2-propanediol.
    Maass AR; Carey PL; Heming AE
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):1-10. PubMed ID: 5357005
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid hormone-catecholamine interrelationships.
    Galton VA
    Endocrinology; 1965 Aug; 77(2):278-84. PubMed ID: 5836169
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular and plasma protein determinants in the differential distribution and metabolism of D- and L-thyroxine in the rat.
    Shapiro HC; Surks MI; Oppenheimer JH
    Endocrinology; 1971 Jan; 88(1):93-101. PubMed ID: 5538564
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of erythrosine (2',4',5',7'-tetraiodofluorescein) on the metabolism of thyroxine in rat liver.
    Ruiz M; Ingbar SH
    Endocrinology; 1982 May; 110(5):1613-7. PubMed ID: 6280969
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of 2-diethylaminoethyl-2.2-diphenylvalerate hydrochloride on the uterotropic action of o.p'-DDT.
    Zeitoun R; Makar AB
    Pharmazie; 1973 Oct; 28(10):673-5. PubMed ID: 4783554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.